ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE, USE OF ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE AS MEDICINE, PARTICULARLY FOR PROPYLAXIS AND TREATMENT OF INFECTIONS OF RESPIRATORY TRACT CAUSED BY HUMAN METAPNEUMOVIRUS (HMPV), HUMAN RHINOVIRUSES (HRV), AND INFECTION BY INFLUENZA VIRUS TYPE A (IAV) AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE
MARIA NOWAKOWSKA,KRZYSZTOF SZCZUBIALKA,KRZYSZTOF PYRC,JUSTYNA CIEJKA,MAGDALENA WYTRWAL,ALEKSANDRA MILEWSKA
申请号：
US15329324
公开号：
US20170216347A1
申请日:
2015.07.29
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The subject of the invention is an N-sulfonic polyallylamine derivative (NSPAH) with Formula 1, wherein R is —SO3− or —H, and n is an integer from 150 to 15000； an application of the N-sulfonic polyallylamine derivative as a medicine, particularly for prevention and treatment of respiratory tract infections caused by the human metapneumovirus (hMPV), respiratory tract infections caused by the human rhinoviruses (HRV), and infections caused by the influenza A virus； as well as a pharmaceutical composition comprising the N-sulfonic polyallylamine derivative and application thereof.
